MedPath

Comparing Dexamethasone With Dexmedetomidine as Additives to Bupivacaine in Adductor Canal Block for Knee Arthroscopy.

Not Applicable
Completed
Conditions
Pain, Postoperative
Interventions
Procedure: ultrasound-guided Adductor Canal Block
Procedure: Spinal anaesthesia
Procedure: ultrasound-guided Adductor Canal Block + dexmedetomedine
Procedure: ultrasound-guided Adductor Canal Block + dexamethasone
Registration Number
NCT04631822
Lead Sponsor
Rasha Hamed
Brief Summary

a comparison shall be conducted between dexamethasone accompanied by bupivacaine, on one hand, and dexmedetomedine accompanied by bupivacaine on the other hand and a control group for pain-free knee arthroscopic surgeries.

Detailed Description

Arthroscopic knee surgery can cause significant postoperative pain to the degree that can potentially delay timely discharge from the ambulatory surgical setting. Analgesia after knee surgery can be provided by multiple, non-systemic, non-opioid-based methods, including local anesthetic infiltration, peripheral nerve blockade, neuraxial procedures, and intra-articular injections. The femoral nerve block has been shown to be superior to traditional intra-articular injection of local anesthetics in some knee surgeries, but motor blockade of the quadriceps muscle, with the potential risk for falls, limits the value of femoral blocks for less invasive ambulatory surgery. Orthopedic surgery is increasingly being performed on an ambulatory basis, where perioperative analgesia can improve timely discharge in the outpatient setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Adult patients of aged more than 18 years old ASA "American Society of Anaesthesia"
  • physical status I or II under-going any unilateral knee arthroscopy.
Exclusion Criteria
  • patient refusal.
  • Pre-existing pain ; postoperative pain similar to preoperative pain
  • Known contraindications to peripheral nerve block, including local skin infections, bleeding diathesis, and coagulopathy.
  • Allergies to local anesthetics, dexmedetomidine, or any component of multimodal analgesia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupultrasound-guided Adductor Canal BlockAll patients will receive spinal anesthesia with 3 ml 0.5% hyperbaric bupivacaine at the L3/4 interspaces in the setting position. Ultrasound blocks will be done immediately after spinal anesthesia, before surgical intervention. In this arm, patients will receive 20 ml mixture of 0.25% bupivacaine with no additives
Dexmedetomedine, combined with bupivacaine for adductor canal blockultrasound-guided Adductor Canal Block + dexmedetomedineAll patients will receive spinal anesthesia with 3 ml 0.5% hyperbaric bupivacaine at the L3/4 interspaces in the setting position. Ultrasound blocks will be done immediately after spinal anesthesia, before surgical intervention. In this arm, patients will receive 20 ml mixture of 0.25% bupivacaine and 0.5 Mg/kg dexmedetomidine.
Dexamethasone, combined with bupivacaine for adductor canal blockSpinal anaesthesiaAll patients will receive spinal anesthesia with 3 ml 0.5% hyperbaric bupivacaine at the L3/4 interspaces in the setting position. Ultrasound blocks will be done immediately after spinal anesthesia, before surgical intervention. In this arm, patients will receive 20 ml mixture of 0.25% bupivacaine and 8 mg dexamethasone.
Dexamethasone, combined with bupivacaine for adductor canal blockultrasound-guided Adductor Canal Block + dexamethasoneAll patients will receive spinal anesthesia with 3 ml 0.5% hyperbaric bupivacaine at the L3/4 interspaces in the setting position. Ultrasound blocks will be done immediately after spinal anesthesia, before surgical intervention. In this arm, patients will receive 20 ml mixture of 0.25% bupivacaine and 8 mg dexamethasone.
Dexmedetomedine, combined with bupivacaine for adductor canal blockSpinal anaesthesiaAll patients will receive spinal anesthesia with 3 ml 0.5% hyperbaric bupivacaine at the L3/4 interspaces in the setting position. Ultrasound blocks will be done immediately after spinal anesthesia, before surgical intervention. In this arm, patients will receive 20 ml mixture of 0.25% bupivacaine and 0.5 Mg/kg dexmedetomidine.
Primary Outcome Measures
NameTimeMethod
Dynamic Visual Analogue Scale scoremonth 1 postoperative

a scale of 11 points. 0 = no pain, 10=worst pain

Secondary Outcome Measures
NameTimeMethod
24 hours opioid analgesia consumed24 hours postoperative
month 3 opioid analgesiamonth 3 postoperative

amount of oral codeine consumed postoperative

Visual Analogue Scale score24 hours postoperative

a scale of 11 points. 0 = no pain, 10=worst pain

Dynamic Visual Analogue Scale scoremonth 3 postoperative

a scale of 11 points. 0 = no pain, 10=worst pain

Trial Locations

Locations (1)

Rasha Hamed

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath